Related Experiment Videos
Musculoskeletal problems in Parkinson's disease: neglected issues
Young Eun Kim1, Woong-Woo Lee, Ji Young Yun
1Department of Neurology and Movement Disorder Center, Parkinson Study Group, Seoul National University Hospital, Seoul, Republic of Korea.
Parkinsonism & Related Disorders
|April 23, 2013
Summary
Patients with Parkinson disease (PD) experience more musculoskeletal problems than controls. These issues are often undertreated in the PD population, highlighting a need for better management strategies.
Area of Science:
- Neurology
- Orthopedics
- Rheumatology
Background:
- Parkinson disease (PD) is a neurodegenerative disorder affecting motor function.
- Musculoskeletal (MSK) problems are common but their prevalence and characteristics in PD patients compared to controls are not well-defined.
Purpose of the Study:
- To determine the prevalence and clinical features of musculoskeletal problems in patients with Parkinson disease (PD).
- To compare the incidence and characteristics of MSK issues in PD patients versus age- and sex-matched controls.
Main Methods:
- A cohort of 400 PD patients and 138 controls underwent physician-led interviews.
- Data collected focused on the presence, location, and history of musculoskeletal problems.
Main Results:
- Musculoskeletal problems were significantly more prevalent in PD patients (66.3%) than controls (45.7%).
- Low back and shoulder involvement was higher in the PD group, while knee involvement was similar.
- Diagnoses like frozen shoulder, low back pain, osteoporosis, and fractures were more common in PD patients, who also reported lower recovery rates and less treatment.
Conclusions:
- Patients with Parkinson disease exhibit a higher burden of musculoskeletal problems compared to the general population.
- Despite the increased prevalence, PD patients with musculoskeletal issues receive inadequate treatment, indicating a significant gap in care.
Related Concept Videos
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:12Alterations in Muscle Tone ll
Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...